Cardiac implantable electronic device (CIED) infection is a potentially devastating
complication of CIED procedures, causing significant morbidity and mortality for patients. Of …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …

Background: Infection of implanted medical devices has catastrophic consequences. For
cardiac rhythm devices, pre-procedural cefazolin is standard prophylaxis but does not …

The use of cardiac implantable electronic devices (CIEDs) has continued to rise along with
indications for their removal. When confronted with challenging clinical scenarios such as …

Sudden cardiac death is a major public health issue in Canada. However, despite the
overwhelming evidence to support the use of implantable cardioverter defibrillators (ICDs) in …

Background Cardiac implantable electronic device (CIED) infections are associated with
hospitalization, mortality, increased costs, and adverse outcomes. Objective Determine the …

Background Infections of cardiac implantable electronic devices (CIED) are associated with
significant morbidity and mortality. Despite many preventive measures, this condition is …

Increasing numbers of patients with cardiac disease have improved quality of life and
longevity as a result of cardiac implantable electronic devices (CIEDs). CIED infections can …

Background Cardiac implantable electronic device (CIED) implantation is complicated by
infection still at a worrisome rate of 2–5%. Since early on during device implantation …